Clinical Trial Update: A Study of Avastin (Bevacizumab) in Combination With Xelox and Tarceva in Patients With Metastatic Colorectal Cancer. [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating Avastin (bevacizumab) in combination with Xelox (capecitabine and oxaliplatin) and Tarceva (erlotinib) in metastatic colorectal cancer …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Avastin (bevacizumab)
• Eloxatin (oxaliplatin)
• Tarceva (erlotinib)
• Xeloda (capecitabine)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Colorectal Cancer | Phase 2 | Status: COMPLETED | Results posted: 2015-02-06